Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Hair transplantation and micrografting are effective for cosmetic facial enhancement, requiring careful technique and postoperative care for successful outcomes.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Balding people may have higher heart disease risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Minoxidil promotes hair growth but exact mechanism is unknown.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Early attempts at using cloned cells for hair transplants failed, but 3D cell growth showed some promise.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hair from balding and non-balding areas regrows similarly on mice.

There's no significant genetic link between male pattern baldness and COVID-19.

Certain genetic changes in the KAP22-1 gene are linked to better wool quality in Egyptian sheep.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Genetic factors can help predict male pattern baldness risk.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.